← 產業報告目錄

Hearing Aids Market Research Report By Product (Hearing aid devices and Hearing implants), By Type of Hear Loss (Sensorineural hearing loss and Conductive hearing loss), By Patient Type (Adults and Pediatrics), By Technology (Digital and Analog) Forecast to 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-03-05頁數 134報告編號 MRFRHC6892HCR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Hearing Aids Market Research Report By Product (Hearing aid devices and Hearing implants), By Type of Hear Loss (Sensorineural hearing loss and Conductive hearing loss), By Patient Type (Adults and Pediatrics), By Technology (Digital and Analog) Forecast to 2032 Market Overview According to the MRFR analysis, the hearing aids market size was anticipated to reach USD 12,034.01 million in 2023. The hearing devices market is expected to advance at a compound annual growth rate (CAGR) of approximately 8.52% during the forecast period (2025–2032). The global market for hearing aids is expanding swiftly because of a number of fundamental variables. One of the primary causes of this trend is the increasing prevalence of hearing loss, particularly among the elderly. The demand is increasing as a result of the increased awareness of auditory health issues by governments and health organizations worldwide. Furthermore, the expansion of product offerings and the expansion of the clientele have been facilitated by technological advancements such as the development of digital hearing aides and wireless networking capabilities. The increasing disposable income of consumers in a variety of sectors will result in a greater number of individuals having access to hearing aids that can enhance their quality of life. Additionally, the process of purchasing these devices will be simplified. Market Segmentation Hearing implants and hearing aid devices are the two product segments that comprise the global market for hearing aids. Based on the form of hearing loss, the global market is divided into two segments: sensorineural and conductive. The market is divided into two segments based on the category of patient: adults and pediatrics. Technology-wise, the global market for hearing aides is divided between analog and digital. Technology divides the market into two segments: digital and analog. The end-user market is divided into three segments: Medicare/Medicaid, third-party payer, and private pay/out-of-pocket. Local Perspectives The study provides market information for hearing aids in the following regions: North America, Europe, Asia-Pacific, and the rest of the globe. North America was the dominant force in the global market in 2023. Several factors, such as the increasing sales volume of hearing devices, the widespread adoption of less noticeable devices for greater aesthetic appeal, and the introduction of new products, are expected to contribute to North America's maximum growth rate during the forecast period. Europe is anticipated to possess the second-largest share as a result of the substantial government support and the expansion of research into the development of state-of-the-art hearing apparatus. The strategic presence of several businesses in the region, such as GN Store Nord A/S, Senovo, Demant A/S, and WS Audiology, is also expected to contribute to growth. According to the National Institute for Health and Care Excellence (NICE), approximately 1,260 individuals in England currently receive cochlear implants each year. Furthermore, it would encourage market expansion. The aging population and the increasing use of hearing implants are expected to result in the highest compound annual growth rate (CAGR) in Asia Pacific during the projection period. According to Hear-it.org, the number of Australians with hearing loss is estimated to be 3.6 billion. This figure is expected to increase to 7.8 billion by 2060, which is expected to contribute to the nation's economic development. Primary Players Some of the major players in the hearing aids market include Starkey Hearing Technologies, Signia, Oticon, Demant, GN Store Nord, Unitron, Eargo, Cochlear, WS Audiology, Rexton, MED-EL (Medical Electronics), William Demant Holding A/S, Amplifon, Sonova, Audina Hearing Instruments, Beltone, and Hearing Life.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............................................................................................................... 18 2 MARKET INTRODUCTION ............................................................................................................ 20 2.1 DEFINITION .................................................................................................................................................................. 20 2.2 SCOPE OF THE STUDY .............................................................................................................................................. 20 2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 20 3 RESEARCH METHODOLOGY ...................................................................................................... 21 3.1 OVERVIEW .................................................................................................................................................................... 21 3.2 DATA FLOW .................................................................................................................................................................. 23 3.2.1 Data Mining Process ....................................................................................................................................... 23 3.3 PURCHASED DATABASE: ......................................................................................................................................... 24 3.4 SECONDARY SOURCES: ............................................................................................................................................ 25 3.4.1 Secondary Research data flow: ........................................................................................................................ 26 3.5 PRIMARY RESEARCH: ............................................................................................................................................... 27 3.5.1 Primary Research DATA FLOW: ....................................................................................................................... 28 3.5.2 Primary Research: Number of Interviews conducted ........................................................................................ 29 3.5.3 Primary Research: Regional Coverage ............................................................................................................. 29 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 30 3.6.1 Revenue Analysis Approach ............................................................................................................................ 30 3.7 DATA FORECASTING................................................................................................................................................. 31 3.7.1 Data forecasting Type ..................................................................................................................................... 31 3.8 DATA MODELING ........................................................................................................................................................ 32 3.8.1 microeconomic factor analysis: ....................................................................................................................... 32 3.8.2 Data modeling: ............................................................................................................................................... 33 3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 35 4 MARKET DYNAMICS .................................................................................................................... 37 4.1 INTRODUCTION ........................................................................................................................................................... 37 4.2 DRIVERS ......................................................................................................................................................................... 37 4.2.1 Increasing Incidences of Hearing Loss ............................................................................................................ 37 4.2.2 Growth of Elderly/Geriatric Population ............................................................................................................. 37 4.3 RESTRAINTS ................................................................................................................................................................ 37 4.3.1 High Cost and Affordability Issues ................................................................................................................... 37 4.3.2 Stigma and Social Acceptance ........................................................................................................................ 38 4.4 OPPORTUNITY ............................................................................................................................................................. 38 4.4.1 Rise in Disposable Income and Affordability..................................................................................................... 38 4.4.2 Technological Advancements .......................................................................................................................... 38 5 MARKET FACTOR ANALYSIS ...................................................................................................... 39 5.1 PORTER’S FIVE FORCES MODEL ........................................................................................................................... 39 5.1.1 Porter’s Five Forces Model .............................................................................................................................. 39 5.1.1.1 Threat of New Entrants ........................................................................................................................... 39 5.1.1.2 Bargaining Power of Suppliers ................................................................................................................ 40 5.1.1.3 Bargaining Power of Buyers .................................................................................................................... 40 5.1.1.4 Threat of Substitutes .............................................................................................................................. 40 5.1.1.5 Industry Rivalry ....................................................................................................................................... 41 5.2 IMPACT OF COVID-19 ON HEARING AIDS MARKET ....................................................................................... 41 5.3 OTC HEARING AID MARKET TRENDS ................................................................................................................ 41 5.4 PAYMENT MODE ANALYSIS BY REGION .......................................................................................................... 43 6 GLOBAL HEARING AIDS MARKET, BY PRODUCT ..................................................................... 48 6.1 INTRODUCTION ........................................................................................................................................................... 48 6.1.1 Hearing Aid Devices ........................................................................................................................................ 48 6.1.1.1 Behind-the-ear (BTE) Hearing Aids ........................................................................................................... 48 6.1.1.2 In-the-ear (ITE) Hearing Aids ................................................................................................................... 48 6.1.1.3 Canal Hearing Aids ................................................................................................................................. 48 6.1.1.4 Receiver-in-the-ear (RIE) Hearing Aid ....................................................................................................... 48 6.1.1.5 Others .................................................................................................................................................... 48 6.1.2 Hearing Implants ............................................................................................................................................ 48 6.1.2.1 Cochlear Implants .................................................................................................................................. 49 6.1.2.2 Bone-Anchored Hearing Aids (BAHA) ...................................................................................................... 49 7 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS ............................................ 51 7.1 INTRODUCTION ........................................................................................................................................................... 51 7.1.1 Sensorineural Hearing Loss............................................................................................................................. 51 7.1.2 Conductive Hearing Loss ................................................................................................................................ 51 8 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE .............................................................. 53 8.1 INTRODUCTION ........................................................................................................................................................... 53 8.1.1 Adults ............................................................................................................................................................ 53 8.1.2 Pediatrics ....................................................................................................................................................... 53 9 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY .............................................................. 55 9.1 INTRODUCTION ........................................................................................................................................................... 55 9.1.1 Digital ............................................................................................................................................................ 55 9.1.2 Analog ........................................................................................................................................................... 55 10 GLOBAL HEARING AIDS MARKET, BY END USER .................................................................... 57 10.1 INTRODUCTION ........................................................................................................................................................... 57 10.1.1 Private Pay/Out of Pocket ............................................................................................................................... 57 10.1.2 Third Party Payer ............................................................................................................................................ 57 10.1.3 Medicare/Medicaid ......................................................................................................................................... 57 11 GLOBAL HEARING AIDS MARKET, BY REGION ......................................................................... 59 11.1 INTRODUCTION ........................................................................................................................................................... 59 11.1.1 North America ................................................................................................................................................ 60 11.1.1.1 US ......................................................................................................................................................... 62 11.1.1.2 Canada .................................................................................................................................................. 64 11.1.1.3 Mexico .................................................................................................................................................. 65 11.1.2 EUROPE ......................................................................................................................................................... 67 11.1.2.1 Germany ................................................................................................................................................ 69 11.1.2.2 UK ......................................................................................................................................................... 71 11.1.2.3 France ................................................................................................................................................... 72 11.1.2.4 Italy ....................................................................................................................................................... 74 11.1.2.5 Spain ..................................................................................................................................................... 76 11.1.2.6 Rest Of Europe ....................................................................................................................................... 77 11.1.3 ASIA-PACIFIC ................................................................................................................................................. 79 11.1.3.1 Japan .................................................................................................................................................... 81 11.1.3.2 China ..................................................................................................................................................... 83 11.1.3.3 India ...................................................................................................................................................... 84 11.1.3.4 Australia ................................................................................................................................................ 86 11.1.3.5 Rest Of Asia Pacific ................................................................................................................................ 88 11.1.4 SOUTH AMERICA ............................................................................................................................................ 89 11.1.4.1 Brazil ..................................................................................................................................................... 91 11.1.4.2 Colombia ............................................................................................................................................... 93 11.1.4.3 Rest of South America ............................................................................................................................ 95 11.1.5 Middle East & Africa ....................................................................................................................................... 97 11.1.5.1 South Africa ........................................................................................................................................... 99 11.1.5.2 GCC Countries ........................................................................................................................................ 101 11.1.5.3 Rest of Middle East and Africa ................................................................................................................ 103 12 COMPETITIVE LANDSCAPE ........................................................................................................ 105 12.1 INTRODUCTION ........................................................................................................................................................... 105 12.2 MARKET SHARE ANALYSIS, 2023 ....................................................................................................................... 105 13 COMPANY PROFILES .................................................................................................................. 106 13.1 COCHLEAR LIMITED .................................................................................................................................................. 106 13.1.1 COMPANY OVERVIEW ..................................................................................................................................... 106 13.1.2 PRODUCTS OFFERed....................................................................................................................................... 106 13.1.3 SWOT ANALYSIS ............................................................................................................................................ 107 13.1.4 Key Strategy ................................................................................................................................................... 107 13.2 GN HEARING A/S ........................................................................................................................................................ 108 13.2.1 COMPANY OVERVIEW ..................................................................................................................................... 108 13.2.2 PRODUCTS OFFERed....................................................................................................................................... 108 13.2.3 SWOT ANALYSIS ............................................................................................................................................ 109 13.2.4 Key Strategy ................................................................................................................................................... 110 13.3 SONOVA ......................................................................................................................................................................... 111 13.3.1 COMPANY OVERVIEW ..................................................................................................................................... 111 13.3.2 PRODUCTS OFFERed....................................................................................................................................... 112 13.3.3 SWOT ANALYSIS ............................................................................................................................................ 113 13.3.4 Key Strategy ................................................................................................................................................... 113 13.4 WILLIAM DEMANT HOLDING A/S ........................................................................................................................ 114 13.4.1 COMPANY OVERVIEW ..................................................................................................................................... 114 13.4.2 PRODUCTS OFFERed....................................................................................................................................... 115 13.4.3 SWOT ANALYSIS ............................................................................................................................................ 116 13.4.4 Key Strategy ................................................................................................................................................... 117 13.5 STARKEY ....................................................................................................................................................................... 118 13.5.1 COMPANY OVERVIEW ..................................................................................................................................... 118 13.5.2 PRODUCTS OFFERed....................................................................................................................................... 118 13.5.3 SWOT ANALYSIS ............................................................................................................................................ 120 13.5.4 Key Strategy ................................................................................................................................................... 120 13.6 PETROFAC ..................................................................................................................................................................... 121 13.6.1 COMPANY OVERVIEW ..................................................................................................................................... 121 13.6.2 PRODUCTS OFFERed....................................................................................................................................... 121 13.6.3 SWOT ANALYSIS ............................................................................................................................................ 122 13.6.4 Key Strategy ................................................................................................................................................... 122 13.7 HALLIBURTON............................................................................................................................................................. 123 13.7.1 COMPANY OVERVIEW ..................................................................................................................................... 123 13.7.2 PRODUCTS OFFERed....................................................................................................................................... 123 13.7.3 SWOT ANALYSIS ............................................................................................................................................ 124 13.7.4 Key Strategy ................................................................................................................................................... 124 13.8 ZOUNDS HEARING ...................................................................................................................................................... 125 13.8.1 COMPANY OVERVIEW ..................................................................................................................................... 125 13.8.2 PRODUCTS OFFERed....................................................................................................................................... 125 13.8.3 SWOT ANALYSIS ............................................................................................................................................ 126 13.8.4 Key Strategy ................................................................................................................................................... 127 13.9 AUDINA HEARING INSTRUMENTS...................................................................................................................... 127 13.9.1 COMPANY OVERVIEW ..................................................................................................................................... 127 13.9.2 PRODUCTS OFFERed....................................................................................................................................... 128 13.9.3 SWOT ANALYSIS ............................................................................................................................................ 128 13.9.4 Key Strategy ................................................................................................................................................... 129 13.10 AMPLIFON .................................................................................................................................................................... 130 13.10.1 COMPANY OVERVIEW ..................................................................................................................................... 130 13.10.2 PRODUCTS OFFERed....................................................................................................................................... 130 13.10.3 SWOT ANALYSIS ............................................................................................................................................ 130 13.10.4 Key Strategy ................................................................................................................................................... 131 14 DATA CITATIONS ......................................................................................................................... 132
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 33 TABLE 2 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 49 TABLE 3 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 50 TABLE 4 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 50 TABLE 5 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 51 TABLE 6 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 53 TABLE 7 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 55 TABLE 8 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 58 TABLE 9 GLOBAL HEARING AIDS ESTIMATES & FORECAST, BY REGION, 2018–2032 (USD MILLION) 59 TABLE 10 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 60 TABLE 11 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 60 TABLE 12 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 60 TABLE 13 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 61 TABLE 14 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 61 TABLE 15 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 61 TABLE 16 NORTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 61 TABLE 17 US HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 62 TABLE 18 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 62 TABLE 19 US HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 62 TABLE 20 US HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 62 TABLE 21 US HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 63 TABLE 22 US HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 63 TABLE 23 US HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 63 TABLE 24 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 64 TABLE 25 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 64 TABLE 26 CANADA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 64 TABLE 27 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 64 TABLE 28 CANADA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 65 TABLE 29 CANADA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 65 TABLE 30 CANADA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 65 TABLE 31 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 65 TABLE 32 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 66 TABLE 33 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 66 TABLE 34 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 66 TABLE 35 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 66 TABLE 36 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 67 TABLE 37 MEXICO HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 67 TABLE 38 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 67 TABLE 39 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 67 TABLE 40 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 68 TABLE 41 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 68 TABLE 42 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 68 TABLE 43 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 68 TABLE 44 EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 68 TABLE 45 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 69 TABLE 46 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 69 TABLE 47 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 69 TABLE 48 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 70 TABLE 49 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 70 TABLE 50 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 70 TABLE 51 GERMANY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 70 TABLE 52 UK HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 71 TABLE 53 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 71 TABLE 54 UK HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 71 TABLE 55 UK HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 71 TABLE 56 UK HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 72 TABLE 57 UK HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 72 TABLE 58 UK HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 72 TABLE 59 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 72 TABLE 60 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 73 TABLE 61 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 73 TABLE 62 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 73 TABLE 63 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 73 TABLE 64 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 74 TABLE 65 FRANCE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 74 TABLE 66 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 74 TABLE 67 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 74 TABLE 68 ITALY HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 75 TABLE 69 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 75 TABLE 70 ITALY HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 75 TABLE 71 ITALY HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 75 TABLE 72 ITALY HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 75 TABLE 73 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 76 TABLE 74 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 76 TABLE 75 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 76 TABLE 76 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 76 TABLE 77 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 77 TABLE 78 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 77 TABLE 79 SPAIN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 77 TABLE 80 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 77 TABLE 81 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 78 TABLE 82 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 78 TABLE 83 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 78 TABLE 84 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 78 TABLE 85 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 79 TABLE 86 REST OF EUROPE HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 79 TABLE 87 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 79 TABLE 88 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 79 TABLE 89 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 80 TABLE 90 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 80 TABLE 91 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 80 TABLE 92 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 80 TABLE 93 ASIA-PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 81 TABLE 94 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 81 TABLE 95 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 81 TABLE 96 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 81 TABLE 97 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 82 TABLE 98 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 82 TABLE 99 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 82 TABLE 100 JAPAN HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 82 TABLE 101 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 83 TABLE 102 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 83 TABLE 103 CHINA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 83 TABLE 104 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 83 TABLE 105 CHINA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 84 TABLE 106 CHINA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 84 TABLE 107 CHINA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 84 TABLE 108 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 84 TABLE 109 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 84 TABLE 110 INDIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 85 TABLE 111 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 85 TABLE 112 INDIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 85 TABLE 113 INDIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 85 TABLE 114 INDIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 85 TABLE 115 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 86 TABLE 116 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 86 TABLE 117 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 86 TABLE 118 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 86 TABLE 119 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 87 TABLE 120 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 87 TABLE 121 AUSTRALIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 87 TABLE 122 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 88 TABLE 123 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 88 TABLE 124 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 88 TABLE 125 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 88 TABLE 126 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 89 TABLE 127 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 89 TABLE 128 REST OF ASIA PACIFIC HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 89 TABLE 129 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 89 TABLE 130 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 89 TABLE 131 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 90 TABLE 132 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 90 TABLE 133 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 90 TABLE 134 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 91 TABLE 135 SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 91 TABLE 136 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 91 TABLE 137 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 91 TABLE 138 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 91 TABLE 139 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 92 TABLE 140 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 92 TABLE 141 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 92 TABLE 142 BRAZIL HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 92 TABLE 143 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 93 TABLE 144 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 93 TABLE 145 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 93 TABLE 146 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 93 TABLE 147 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 94 TABLE 148 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 94 TABLE 149 COLOMBIA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 94 TABLE 150 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 95 TABLE 151 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 95 TABLE 152 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 95 TABLE 153 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 95 TABLE 154 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 96 TABLE 155 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 96 TABLE 156 REST OF SOUTH AMERICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 96 TABLE 157 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 97 TABLE 158 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 97 TABLE 159 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 97 TABLE 160 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 97 TABLE 161 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 98 TABLE 162 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 98 TABLE 163 MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 98 TABLE 164 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 99 TABLE 165 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 99 TABLE 166 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 99 TABLE 167 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 99 TABLE 168 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 100 TABLE 169 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 100 TABLE 170 SOUTH AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 100 TABLE 171 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 101 TABLE 172 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 101 TABLE 173 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 101 TABLE 174 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 101 TABLE 175 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 102 TABLE 176 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 102 TABLE 177 GCC COUNTRIES HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 102 TABLE 178 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PRODUCT, 2018–2032 (USD MILLION) 103 TABLE 179 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING AID DEVICES, 2018–2032 (USD MILLION) 103 TABLE 180 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY HEARING IMPLANTS, 2018–2032 (USD MILLION) 103 TABLE 181 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TYPE OF HEARING LOSS, 2018–2032 (USD MILLION) 103 TABLE 182 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY PATIENT TYPE, 2018–2032 (USD MILLION) 104 TABLE 183 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY TECHNOLOGY, 2018–2032 (USD MILLION) 104 TABLE 184 REST OF MIDDLE EAST AND AFRICA HEARING AIDS ESTIMATES & FORECAST, BY END USER, 2018–2032 (USD MILLION) 104 TABLE 185 COCHLEAR LIMITED COMPANY: PRODUCTS OFFERED 106 TABLE 186 GN HEARING A/S: PRODUCTS OFFERED 108 TABLE 187 SONOVA: PRODUCTS OFFERED 112 TABLE 188 WILLIAM DEMANT HOLDING A/S.: PRODUCTS OFFERED 115 TABLE 189 STARKEY: PRODUCTS OFFERED 118 TABLE 190 PETROFAC PRODUCTS OFFERED 121 TABLE 191 HALLIBURTON PRODUCTS OFFERED 123 TABLE 192 ZOUNDS HEARING PRODUCTS OFFERED 125 TABLE 193 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED 128 TABLE 194 AUDINA HEARING INSTRUMENTS PRODUCTS OFFERED 130 LIST OF FIGURES FIGURE 1 GLOBAL HEARING AIDS MARKET, BY PRODUCT, 2023 (% SHARE) 49 FIGURE 2 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2023 (% SHARE) 52 FIGURE 3 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE, 2023 (% SHARE) 54 FIGURE 4 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY, 2023 (% SHARE) 56 FIGURE 5 GLOBAL HEARING AIDS MARKET, BY END USER, 2023 (% SHARE) 58 FIGURE 6 GLOBAL HEARING AIDS MARKET MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%) 105 FIGURE 7 COCHLEAR LIMITED COMPANY: SWOT ANALYSIS 107 FIGURE 8 GN HEARING A/S: SWOT ANALYSIS 109 FIGURE 9 SONOVA: SWOT ANALYSIS 113 FIGURE 10 WILLIAM DEMANT HOLDING A/S.: SWOT ANALYSIS 116 FIGURE 11 STARKEY: SWOT ANALYSIS 120 FIGURE 12 PETROFAC SWOT ANALYSIS 122 FIGURE 13 HALLIBURTON SWOT ANALYSIS 124 FIGURE 14 ZOUNDS HEARING SWOT ANALYSIS 126 FIGURE 15 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS 128 FIGURE 16 AUDINA HEARING INSTRUMENTS SWOT ANALYSIS 130

提及公司

Starkey Hearing TechnologiesSigniaOticonDemantGN Store NordUnitronMED-EL (Medical Electronics)William Demant Holding A/SEargoCochlearWS AudiologyRextonAmplifonSonovaAudina Hearing InstrumentsBeltoneand Hearing Life

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們